JP2004514675A5 - - Google Patents

Download PDF

Info

Publication number
JP2004514675A5
JP2004514675A5 JP2002544424A JP2002544424A JP2004514675A5 JP 2004514675 A5 JP2004514675 A5 JP 2004514675A5 JP 2002544424 A JP2002544424 A JP 2002544424A JP 2002544424 A JP2002544424 A JP 2002544424A JP 2004514675 A5 JP2004514675 A5 JP 2004514675A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002544424A
Other languages
Japanese (ja)
Other versions
JP2004514675A (ja
JP4427249B2 (ja
Filing date
Publication date
Priority claimed from HU0004701A external-priority patent/HU226998B1/hu
Application filed filed Critical
Publication of JP2004514675A publication Critical patent/JP2004514675A/ja
Publication of JP2004514675A5 publication Critical patent/JP2004514675A5/ja
Application granted granted Critical
Publication of JP4427249B2 publication Critical patent/JP4427249B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2002544424A 2000-11-23 2001-11-14 新規デスロラタジン塩、その合成方法および医薬組成物 Expired - Lifetime JP4427249B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0004701A HU226998B1 (en) 2000-11-23 2000-11-23 Desloratadine hemisulphate, process for the preparation thereof and pharmaceutical compositions containing the same
PCT/HU2001/000111 WO2002042290A1 (en) 2000-11-23 2001-11-14 New desloratadine salts, process for their synthesis and pharmaceutical compositions thereof

Publications (3)

Publication Number Publication Date
JP2004514675A JP2004514675A (ja) 2004-05-20
JP2004514675A5 true JP2004514675A5 (enExample) 2005-12-22
JP4427249B2 JP4427249B2 (ja) 2010-03-03

Family

ID=89978790

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002544424A Expired - Lifetime JP4427249B2 (ja) 2000-11-23 2001-11-14 新規デスロラタジン塩、その合成方法および医薬組成物

Country Status (19)

Country Link
US (1) US7196195B2 (enExample)
EP (1) EP1347965B1 (enExample)
JP (1) JP4427249B2 (enExample)
CN (1) CN1199968C (enExample)
AT (1) ATE316525T1 (enExample)
AU (1) AU2002218422A1 (enExample)
CA (1) CA2425422C (enExample)
CY (1) CY1105595T1 (enExample)
CZ (1) CZ304694B6 (enExample)
DE (1) DE60116902T2 (enExample)
DK (1) DK1347965T3 (enExample)
ES (1) ES2257467T3 (enExample)
HU (1) HU226998B1 (enExample)
NO (1) NO325155B1 (enExample)
PL (1) PL206973B1 (enExample)
RU (1) RU2285001C2 (enExample)
SK (1) SK285715B6 (enExample)
UA (1) UA74858C2 (enExample)
WO (1) WO2002042290A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003086275A2 (en) * 2002-04-15 2003-10-23 Sun Pharmaceutical Industries Limited Preperation of desloratatine
HRP20050110A2 (en) * 2002-08-05 2006-02-28 Sandoz Ag Novel salt and polymorphs of desloratadine hemifumarate
JP4501015B2 (ja) 2004-03-17 2010-07-14 味の素株式会社 アミノピリミジン化合物の製造方法
EA011894B1 (ru) * 2004-07-07 2009-06-30 Эгиш Дьёдьсердьяр Нирт. Новая псевдополиморфная форма деслоратадина, образованная с диоксидом углерода
CA2541045A1 (en) * 2006-03-24 2007-09-24 Pharmascience Inc. A descarbonylethoxyloratadine containing pharmaceutical composition
EP2837631A1 (en) * 2013-08-14 2015-02-18 Merck & Cie New stable salt of 5,10-methylene-(6R)-tetrahydrofolic acid
AU2020372682A1 (en) * 2019-10-31 2022-06-09 Jd Bioscience Inc. Tricyclic compound and pharmaceutical use thereof
CN115785065A (zh) * 2022-12-02 2023-03-14 山东达因海洋生物制药股份有限公司 一种地氯雷他定共晶及其制备方法与应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4282233B1 (en) * 1980-06-19 2000-09-05 Schering Corp Antihistaminic 11-(4-piperidylidene)-5h-benzoÄ5,6Ü-cyclohepta-Ä1,2Ü-pyridines
WO1985003707A1 (en) * 1984-02-15 1985-08-29 Schering Corporation 8-CHLORO-6,11-DIHYDRO-11-(4-PIPERIDYLIDENE)-5H-BENZO AD5,6 BDCYCLOHEPTA AD1,2-b BDPYRIDINE AND ITS SALTS, PROCESSES FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS
EP0208855B1 (en) * 1985-05-13 1991-03-06 Schering Corporation process for preparing piperidylidene dihydrodibenzo(a,d)cycloheptenes and aza derivatives thereof, compounds obtained by such process and the use of such compounds for preparing useful pharmaceutical compositions
PT656348E (pt) * 1993-12-03 2000-10-31 Hoffmann La Roche Derivados do acido acetico como medicamentos
GB9709945D0 (en) * 1997-05-17 1997-07-09 Glaxo Group Ltd A novel salt
SK287105B6 (sk) * 1999-12-20 2009-12-07 Schering Corporation Dvojvrstvový orálny dávkový prostriedok s predĺženým uvoľňovaním
RU2164796C1 (ru) * 2000-05-25 2001-04-10 Открытое акционерное общество "Химико-фармацевтический комбинат "Акрихин" Противогистаминное средство и способ его получения

Similar Documents

Publication Publication Date Title
BE2022C547I2 (enExample)
BE2017C057I2 (enExample)
BE2017C051I2 (enExample)
BE2017C032I2 (enExample)
BE2016C051I2 (enExample)
BE2015C077I2 (enExample)
BE2014C052I2 (enExample)
BE2014C036I2 (enExample)
BE2014C026I2 (enExample)
BE2014C004I2 (enExample)
BE2012C022I2 (enExample)
BE2007C047I2 (enExample)
BE2011C034I2 (enExample)
BE2014C006I2 (enExample)
BRPI0209186B1 (enExample)
BE2017C050I2 (enExample)
BRPI0204884A2 (enExample)
CH1379220H1 (enExample)
BE2014C008I2 (enExample)
BE2016C021I2 (enExample)
BRPI0101486B8 (enExample)
BE2012C051I2 (enExample)
JP2002189721A5 (enExample)
BRPI0210463A2 (enExample)
JP2002211830A5 (enExample)